Godavari Biorefineries touches the roof on securing European patent for novel anticancer molecule
Godavari Biorefineries is currently trading at its upper circuit limit of Rs 258.60, up by 12.30 points or 4.99% from its previous closing of Rs 246.30 on the BSE.
The scrip opened at Rs 258.60 and has touched a high and low of Rs 258.60 and Rs 250.00 respectively. So far 20814 shares were traded on the counter.
The BSE group 'T' stock of face value Rs 10 has touched a 52-week high of Rs 408.25 on 09-Dec-2024 and a 52-week low of Rs 145.20 on 28-Mar-2025.
Last one week high and low of the scrip stood at Rs 258.60 and Rs 236.50 respectively. The current market cap of the company is Rs 1323.41 crore.
The promoters holding in the company stood at 63.31%, while Institutions and Non-Institutions held 15.14% and 21.55% respectively.
Godavari Biorefineries has secured European patent for a novel anticancer molecule. This patent is now validated in Spain, the UK, and as a Unitary Patent. The patent subject area is ‘Anti-Cancer Research Segment’ and the patent covers very potent anticancer compound with proven efficacy on cancer and cancer stem cell.
Godavari Biorefineries is one of the manufacturers of ethanol based chemicals in India. Its diversified product portfolio comprises of bio-based chemicals, sugar, different grades of ethanol and power.
